CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- Open-market buys, last 90 days
- $60,455
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$60,455. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-10 | Treco James Director | Grant or award · Stock Option | +270,882 | 270,882 | ||
| 2021-05-10 | OLUKOTUN ADEOYE Y Director | Grant or award · Stock Option | +270,882 | 270,882 | ||
| 2021-05-10 | GRANGE DAVID L Director | Grant or award · Stock Option | +270,882 | 270,882 | ||
| 2021-05-10 | Goodman Daniel Wintner Director | Grant or award · Stock Option | +270,882 | 270,882 | ||
| 2021-05-10 | Bell Margaret Smith Director | Grant or award · Stock Option | +270,882 | 270,882 | ||
| 2021-05-10 | BAGGER RICHARD H Director | Grant or award · Stock Option | +270,882 | 270,882 | ||
| 2021-03-24 | LEDERMAN SETH Chief Executive Officer | Purchase | +16,733 | $1.32 | $22K | 135,000 |
| 2021-02-23 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +3,000,000 | 3,000,000 | ||
| 2021-02-23 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +3,000,000 | 3,000,000 | ||
| 2021-02-23 | SAENGER BRADLEY Chief Financial Officer | Grant or award · Stock Option | +540,000 | 540,000 | ||
| 2021-02-23 | SAENGER BRADLEY Chief Financial Officer | Grant or award · Stock Option | +540,000 | 540,000 | ||
| 2021-02-23 | MORRIS JESSICA EDGAR Chief Operating Officer | Grant or award · Stock Option | +540,000 | 540,000 | ||
| 2021-02-23 | MORRIS JESSICA EDGAR Chief Operating Officer | Grant or award · Stock Option | +540,000 | 540,000 | ||
| 2021-02-23 | SULLIVAN GREGORY M Chief Medical Officer | Grant or award · Stock Option | +750,000 | 750,000 | ||
| 2021-02-23 | SULLIVAN GREGORY M Chief Medical Officer | Grant or award · Stock Option | +750,000 | 750,000 | ||
| 2021-01-07 | SULLIVAN GREGORY M Chief Medical Officer | Grant or award | +41,322 | $0.51 | $21K | 62,727 |
| 2020-12-30 | LEDERMAN SETH Chief Executive Officer | Purchase | +35,000 | $0.68 | $24K | 118,267 |
| 2020-08-31 | Treco James Director | Purchase | +5,500 | $0.89 | $5K | 10,000 |
| 2020-08-20 | Bell Margaret Smith Director | Purchase | +5,391 | $0.93 | $5K | 5,391 |
| 2020-08-17 | SULLIVAN GREGORY M Chief Medical Officer | Purchase | +20,000 | $1.03 | $21K | 21,405 |
Page 7 of 25 · 482 trades